IMMUNOTECH-B (06978) plans to issue new convertible bonds and notes totaling 270 million yuan to Jiaze Global Capital to repay the principal amount of the convertible bonds due in 2023.

IMMUNOTECH-B (06978) announced that the convertible bonds due in 2023 will be issued on February 20, 2023 and will mature on February 20, 2026. On January 20, 2026 (after trading hours), the company entered into a framework agreement with investor Jiaze Global Capital Limited (the current holder of the 2023 convertible bonds), under which the investor agreed to subscribe for a principal amount of 270 million yuan of new convertible bonds and 30 million yuan of notes. The proceeds from the subscription will be used specifically for the full and final repayment of the principal amount of the 2023 convertible bonds. The initial conversion price of the new convertible bonds is HK$2.92 per share (adjustable), representing a premium of approximately 5.8% over the closing price of HK$2.76 per share on the last trading day on the Stock Exchange of Hong Kong.